Expert Review of Pharmacoeconomics and Outcomes Research, 1473-7167

Tidskrift

Fler filtreringsmöjligheter
  1. 2018
  2. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT)

    Wagenlehner, F., Wullt, B., Ballarini, S., Zingg, D. & Naber, K. G., 2018, I : Expert Review of Pharmacoeconomics and Outcomes Research. 18, 1, s. 107-117

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2017
  4. Transposition and implementation of EU rare disease policy in Eastern Europe

    Pejcic, A. V., Iskrov, G., Raycheva, R., Stefanov, R. & Jakovljevic, M. M., 2017 dec, I : Expert Review of Pharmacoeconomics & Outcomes Research. 17, 6, s. 557-566 10 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  5. 2016
  6. Life expectancy and health expenditure evolution in Eastern Europe-DiD and DEA analysis

    Mihajlo B Jakovljevic, Vukovic, M. & Fontanesi, J., 2016 aug, I : Expert Review of Pharmacoeconomics & Outcomes Research. 16, 4, s. 537-46

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Advantages and disadvantages of discrete-event simulation for health economic analyses.

    Caro, J. J. & Möller, J., 2016, I : Expert Review of Pharmacoeconomics & Outcomes Research.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2015
  9. Evolution of the Serbian pharmaceutical market alongside socioeconomic transition

    Mihajlo B Jakovljevic, Djordjevic, N., Jurisevic, M. & Jankovic, S., 2015 jun, I : Expert Review of Pharmacoeconomics & Outcomes Research. 15, 3, s. 521-30

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. 2014
  11. 10th World IHEA and ECHE Joint Congress: health economics in the age of longevity

    Mihajlo B Jakovljevic, Getzen, T. E., Torbica, A. & Anegawa, T., 2014 dec, I : Expert Review of Pharmacoeconomics & Outcomes Research. 14, 6, s. 781-783

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  12. Contemporary generic market in Japan - key conditions to successful evolution

    Mihajlo B Jakovljevic, Nakazono, S. & Ogura, S., 2014 apr, I : Expert Review of Pharmacoeconomics & Outcomes Research. 14, 2, s. 181-94 14 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  13. 2010
  14. Health, happiness, inequality

    Karlsson, M., Therese Nilsson & Carl Hampus Lyttkens, 2010, I : Expert Review of Pharmacoeconomics & Outcomes Research. 10, 1, s. 497-500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2008
  16. Social capital, social class and tobacco smoking

    Martin Lindström, 2008, I : Expert Review of Pharmacoeconomics and Outcomes Research. 8, 1, s. 81-89 9 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  17. 2005
  18. Feasibility and linguistic validity of the Swedish version of the PDQ-39

    Hagell, P., 2005, I : Expert Review of Pharmacoeconomics & Outcomes Research. 5, 2, s. 131-136

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. 2004
  20. Changes in drug spending for different age groups during the 1990s? Evidence from Sweden

    Ulf Gerdtham & Lundin, D., 2004, I : Expert Review of Pharmacoeconomics and Outcomes Research. 4, 3, s. 343-351 19 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift